Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIBERTY 360: Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients With Distal Outflow Peripheral Arterial Disease (PAD)

NCT01855412 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01855412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01855412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIBERTY 360: Prospective, Observational, Multi-Center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients With Distal Outflow Peripheral Arterial Disease (PAD)
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
April 11, 2019
Enrollment
1,204 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial occlusive disease